Sermorelin

Heart attack, while acutely life-threatening, can also lead to long-term disability secondary to heart failure, cardiac conduction abnormalities (arrhythmias), reduced exercise capacity, pain, and more. A number of these problems result from cardiac remodeling that follows damage to myocytes (heart muscle cells). Often, cardiac remodeling leads not only to scarring in the area of damage following a heart attack, but in surrounding, undamaged areas as well. This remodeling causes a number of long-term problems and research has shown that preventing it from happening can significantly improve outcomes both immediately after heart attack and years down the line.

• reduces cell death in cardiomyocytes,
• increases the growth of blood vessels to damaged tissue, and
• reduces the production of substances that causes damaging inflammation.

Clinically, sermorelin’s effects are seen in improved diastolic function, reduced scar size, and increased capillary growth[1], [2]. There is current research exploring the benefits of sermorelin in other forms of heart disease, such as heart failure and even valve disorders.